Clinical trials recruiting in Chisinau, Moldova

Phase breakdown

Conditions recruiting in Chisinau, Moldova

Recruiting trials in Chisinau, Moldova

• A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
  NCT07363590 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
  NCT07111520 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis
  NCT06671054 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
  NCT07184944 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female)
• A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis
  NCT07533955 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female)
• A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity
  NCT06842186 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female)
• A Phase 1b Open-label Study to Evaluate Safety of Plamotamab in Participants With Rheumatoid Arthritis
  NCT07230353 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female)
• A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
  NCT06226883 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female)
• A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
  NCT07113522 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female)
• A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
  NCT05910827 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
  NCT06996782 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
  NCT06613360 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female)
• A Study of LY3971297 in Participants With Heart Failure
  NCT07547540 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female)
• A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
  NCT07012395 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis
  NCT07374471 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B
  NCT07389044 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female)
• A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis
  NCT07433335 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female)
• A Study to Compare Efficacy, Pharmacokinetics, Safety and Immunogenicity of MB04 [proposed Etanercept Biosimilar] to Enbrel® [EU-sourced] in Rheumatoid Arthritis
  NCT06596772 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
  NCT06975722 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
  NCT05704361 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female)
• A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.
  NCT06917404 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
  NCT06219941 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
  NCT07184931 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female)
• An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
  NCT07184996 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female)
• BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
  NCT06120283 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female)
• Confirmatory Clinical Study in Active Ulcerative Colitis
  NCT07296315 · Phase: Phase 2 · Ages: 16 Years and older · Sex: All (male and female)
• Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis
  NCT06833749 · Phase: Phase 2 · Ages: 45 Years and older · Sex: All (male and female)
• Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)
  NCT06277037 · Phase: Not specified · Ages: 20 Years to 70 Years · Sex: All (male and female)
• PRIDE III Prison Interventions and HIV Prevention Collaboration
  NCT06962033 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B
  NCT06680232 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female)
• Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B
  NCT06671093 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
  NCT06850727 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Study of GS-0151 in Participants With Rheumatoid Arthritis
  NCT06902519 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis
  NCT07207954 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
  NCT06619990 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Validation of Sudden Cardiac Arrest Risk Factors in Patients With CAD
  NCT07444931 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Chisinau, Moldova?

36 recruiting trials have at least one study site in Chisinau, Moldova.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.